BeiGene (BGNE)
(Delayed Data from NSDQ)
$144.12 USD
+5.13 (3.69%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $144.12 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Income Statements
Fiscal Year end for BeiGene, Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,459 | 1,416 | 1,176 | 309 | 428 |
Cost Of Goods | 380 | 286 | 165 | 71 | 71 |
Gross Profit | 2,079 | 1,129 | 1,011 | 238 | 357 |
Selling & Adminstrative & Depr. & Amort Expenses | 3,287 | 2,919 | 2,450 | 1,896 | 1,317 |
Income After Depreciation & Amortization | -1,208 | -1,790 | -1,439 | -1,658 | -960 |
Non-Operating Income | 382 | -171 | 16 | 39 | 16 |
Interest Expense | 0 | 0 | 16 | 0 | 0 |
Pretax Income | -826 | -1,961 | -1,439 | -1,618 | -944 |
Income Taxes | 56 | 43 | -25 | -18 | 7 |
Minority Interest | 0 | 0 | 0 | -4 | -2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -882 | -2,004 | -1,413 | -1,601 | -951 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -882 | -2,004 | -1,413 | -1,597 | -949 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -1,120 | -1,723 | -1,392 | -1,740 | -941 |
Depreciation & Amortization (Cash Flow) | 88 | 66 | 46 | -82 | 19 |
Income After Depreciation & Amortization | -1,208 | -1,790 | -1,439 | -1,658 | -960 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 104.39 | 103.13 | 92.79 | 83.47 | 60.05 |
Diluted EPS Before Non-Recurring Items | -8.45 | -19.43 | -15.23 | -19.13 | -15.80 |
Diluted Net EPS (GAAP) | -8.45 | -19.43 | -15.23 | -19.13 | -15.80 |
Fiscal Year end for BeiGene, Ltd falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 634.41 | 781.31 | 595.26 | 447.80 |
Cost Of Goods | NA | 105.83 | 96.31 | 95.99 | 81.79 |
Gross Profit | NA | 528.58 | 685.00 | 499.27 | 366.01 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 912.38 | 818.97 | 817.98 | 737.27 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -383.80 | -133.97 | -318.71 | -371.26 |
Non-Operating Income | NA | 33.02 | 363.31 | -48.75 | 34.32 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -350.77 | 229.34 | -367.46 | -336.94 |
Income Taxes | NA | 16.78 | 13.93 | 13.67 | 11.49 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -367.55 | 215.41 | -381.14 | -348.43 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -367.55 | 215.41 | -381.14 | -348.43 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 104.08 | 106.95 | 104.63 | 104.17 |
Diluted EPS Before Non-Recurring Items | NA | -3.53 | 2.01 | -3.64 | -3.34 |
Diluted Net EPS (GAAP) | NA | -3.48 | 2.01 | -3.64 | -3.34 |